William Castell, Douglas Berthiaume, Mark Beaudouin, John Ornell | GenomeWeb

William Castell, who became vice chairman of General Electric and CEO of GE Healthcare after GE acquired Amersham last year in a $10 billion deal, is functioning under a two-year employment agreement, according to GE's proxy statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.